Ziccum AB (publ) releases Q2 Report 2021

  • by ziccum-admin

    • (Lund, Sweden, 26 August 2021) Ziccum AB today releases its Q2 Report for 2021. For the first time the Report will also be released in a digital online format allowing subscribers and readers to more easily interact with and navigate every aspect of the Report.

    Read the Q2 Report in its new digital format here:   https://reports.ziccum.com/delarsrapport-q2-2021/start/

    The PDF of the Report is attached to this Press Release, and is available on the company’s website on: https://ziccum.com/investors/financial-reports/

    For more information about Ziccum, please contact:

    Göran Conradson: CEO Ziccum AB
    Mail: conradson@ziccum.com
    Mobile: +46 709 61 55 99
     
    Certified Adviser
    Erik Penser Bank AB
    Mail: certifiedadviser@penser.se
    Phone: +46 8 463 83 00

    About Ziccum

    Ziccum develops new thermostable versions of the world's most urgently needed, life-saving vaccines. The Company's patented technology, LaminarPace, enables the production of new, gently air-dried formulations that can be transported easily and cost-effectively, with no need for a costly and complicated cold chain, all the way from the factory to the last child in the last mile of the supply chain.

    Attachments

    Ziccum Q2 2021

    Ziccum Q2 2021